Seeking Alpha
Recommended for you:
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Do you like to invest with a stock's momentum trends? For ideas on how to start your own momentum search, we ran a screen.

We began by screening the healthcare sector for stocks that have outperformed the market over the last quarter, with quarterly performance above 20%.

We then screened for those stocks with strong sales trends, comparing growth in revenue to growth in accounts receivable. Since accounts receivable is the portion of revenue not yet received, and there is no guarantee the money will ever be received, the smaller the portion of revenue made up of receivables the healthier the company's revenue.

We screened for stocks seeing faster growth in revenue than accounts receivable year-over-year, as well as accounts receivable comprising a smaller portion of current assets over the same time period.

Interactive Chart: Press Play to compare changes in market cap over the last two years for the stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Do you think these stocks will continue to outperform? Use this list as a starting point for your own analysis.

List sorted by increase in revenue over the last year.

1. NuVasive, Inc. (NASDAQ:NUVA): Engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. Market cap at $905.92M, most recent closing price at $20.68. Performance over the last quarter at 28.22%. Revenue grew by 21.87% during the most recent quarter ($151.69M vs. $124.47M y/y). Accounts receivable grew by 12.67% during the same time period ($85.57M vs. $75.95M y/y). Receivables, as a percentage of current assets, decreased from 19.35% to 13.58% during the most recent quarter (comparing 3 months ending 2012-03-31 to 3 months ending 2011-03-31).

2. eResearchTechnology, Inc. (NASDAQ:ERT): Provides technological services and medical devices in North America and the United Kingdom. Market cap at $389.49M, most recent closing price at $7.91. Performance over the last quarter at 39.08%. Revenue grew by 16.46% during the most recent quarter ($52.29M vs. $44.9M y/y). Accounts receivable grew by 11.76% during the same time period ($41.62M vs. $37.24M y/y). Receivables, as a percentage of current assets, decreased from 44.98% to 40.73% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

3. MEDTOX Scientific Inc. (NASDAQ:MTOX): Provides forensic and clinical laboratory services, and offers diagnostic devices. Market cap at $183.17M, most recent closing price at $20.31. Performance over the last quarter at 30.39%. Revenue grew by 13.86% during the most recent quarter ($28.58M vs. $25.1M y/y). Accounts receivable grew by -6.54% during the same time period ($18.86M vs. $20.18M y/y). Receivables, as a percentage of current assets, decreased from 66.62% to 54.4% during the most recent quarter (comparing 3 months ending 2012-03-31 to 3 months ending 2011-03-31).

4. US Physical Therapy Inc. (NYSE:USPH): Operates outpatient physical and occupational therapy clinics in the United States. Market cap at $292.72M, most recent closing price at $24.64. Performance over the last quarter at 21.03%. Revenue grew by 10.29% during the most recent quarter ($62.58M vs. $56.74M y/y). Accounts receivable grew by 5.01% during the same time period ($31.43M vs. $29.93M y/y). Receivables, as a percentage of current assets, decreased from 67.93% to 66.7% during the most recent quarter (comparing 3 months ending 2012-03-31 to 3 months ending 2011-03-31).

*Accounting data sourced from Google Finance, all other data sourced from Finviz.

Source: 4 Outperforming Healthcare Stocks With Strong Sales Trends